Tag:
MRSA
Latest Headlines
Latest Headlines
First 'cross-kingdom' vax effective in PhI
NovaDigm Therapeutics is developing a vaccine that could work against both bacteria and fungi, and could even combat resistant bacteria such as MRSA. The company presented Phase I results at the 15th Annual Conference on Vaccine Research.
MRSA research lags far behind AIDS in NIH support
Some researchers recently crunched the numbers of federal drug research support and concluded that despite all the alarms over drug-resistant superbugs each MRSA death translated into only $570 in
Pomp and contamination at commencement?
Tried as they might, researchers from the Johns Hopkins Bloomberg School of Public Health did not succeed in taking the joy out commencement season. Aside from an annual dusting off of Bartlett's
Biotechs pick up slack in antibiotics development
While Big Pharma still has a strong foothold in the antibiotics market, smaller biotechs have tackled the job of replenishing our arsenal of new weapons against infections--especially so-called
Semiconductor technique could attack MRSA
Antibiotic-resistant bacteria and infectious diseases, like Methicillin-resistant Staphylococcus aureus (MRSA), are big problems in institutions like jails, hospitals and schools where people come in
Researchers 'unzip' MRSA's armor for possible vaccine
MRSA (methicillin-resistant staphylococcus aureus) is one tough nut to crack. Researchers have failed to produce a vaccine because agents cannot break through the life-threatening bacteria's armor.
Scientists enlist cockroaches in the war against superbugs
It turns out that cockroaches may be good for something other than stepping on. Scientists say that the "brains" of the cockroach, one of the globe's most tenacious survivors, are loaded with
MRSA vax breakthrough reported by UChicago team
With the deadly MRSA bacteria making the rounds at hospitals with increasing frequency, investigators have highlighted two new research developments that could help pave the way to a new vaccine for
Drug-resistant superbug highlights need for new antibiotics
A new superbug equipped with a gene that renders the current generation of antibiotics useless has begun to spread around the globe. The bacteria--which is armed with the NDM-1 gene--has been found
Syntiron, Sanofi-Pasteur to team up on MRSA vax
Minnesota biotech start-up Syntiron has inked a $149 million licensing deal with Sanofi Pasteur, the vaccines division of Sanofi-Aventis. The partners plan to develop a vaccine against bacteria that
